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Review question
1. What are the differences in trunk, pelvis, hip, knee and ankle joint kinematics and kinetics during walking
between individuals with total hip arthroplasty (THA) for osteoarthritis (OA) and controls? 
Aim: To investigate whether gait biomechanics after THA recover to match those of typical healthy
individuals or those with OA who have not undergone THA 
2. What are the changes in trunk, pelvis, hip, knee and ankle joint kinematics and kinetics during walking pre
to post THA for OA? 
Aim: To establish if the changes in gait biomechanics after THA and the time frame for these changes 
 
Searches
We will search the following electronic databases: 
Cochrane Central Register of Controlled Trials (CENTRAL; current issue) and the Cochrane Database of
Systematic Reviews (CDSR) 
PubMed Ovid 
CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; 1982 to present) 
Web of Science (WoS) 
Physiotherapy Evidence Database (PedRO) 
Sport discus 
EMBASE 
ETHOS 
MEDLINE Ovid 
Reference lists of all included studies and relevant systematic reviews will be scanned for any further studies
which meet the inclusion criteria for the review. 
 
The PECOS framework will be used to define the search strategy (full search strategy can be found in the
supporting document). Eligible languages for inclusion will be restricted to English. 
 
Search strategy
https://www.crd.york.ac.uk/PROSPEROFILES/105048_STRATEGY_20180727.pdf
 
Types of study to be included
All experimental and interventional study designs will be included within the review. Specifically, cohort, case-
control and single group pre-post intervention studies will be included. Randomised control trials (RCTs) will
be included within the review, however data from the single arm cohorts included within the RCT that meet
the inclusion criteria for the review will be included; these studies will then be appraised as though they were
cohort studies. 
Where only partial biomechanical data sets are available these will be extracted and included within the
relevant sections of the review (for instance if a study only reports on hip joint kinematics the study will only
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be included in this component of the review). 
 
Condition or domain being studied
Total hip arthroplasty for osteoarthritis. Changes in biomechanical parameters of the trunk and lower limb
during walking. 
 
Participants/population
Q1. Adults over 18 years old 
 Exposed group: those who have undergone a unilateral THA for osteoarthritis 
 Comparison groups: healthy or OA control groups (no total hip arthroplasty) 
Q2 & 3. Adults over 18 years old requiring a unilateral THA for osteoarthritis 
 Exposed group: before THA 
 Comparison group: after THA 
 
Studies will be excluded if they include patients with bilateral THA, THA for any other reason than
osteoarthritis, other major medical conditions affecting gait (i.e. stroke, multiple sclerosis, cancer, etc.) or
previous surgery (e.g. revision THA, knee or ankle arthroplasty, THA at the other side). Studies that
compared the non-operated leg to the operated leg and studies assessing outcomes of 2D movement
analysis will be excluded. 
 
Intervention(s), exposure(s)
Intervention: primary unilateral THA for osteoarthritis 
Exposures: pre, 6 weeks post, 6 months post, 1 year post and 2+ years post THA 
 
Comparator(s)/control
Q1. Comparator = total hip arthroplasty; Control = matched controls (OA or healthy) 
Q2. Comparator = post-THA (at the following time frames; 6 weeks post, 6 months post, 1 year post and 2+
years post operation); Control = pre-THA 
 
Context
Not applicable
 
Primary outcome(s)
The primary outcomes will be trunk, pelvis, hip, knee, and ankle kinematics and kinetics measured during
walking trials using 3D motion analysis. The biomechanical measures will be analysed before and after THA
and compared between individuals with and without THA. 
 
Secondary outcome(s)
Recovery of the primary outcome measures post-surgery will be assessed at different time points, the time
points to be explored are; 6 weeks, 6 months, 1 year and 2 years +. Patient reported measures of hip pain,
function, quality of life, and participation at the time of the walking trials. Spatial-temporal parameters will be
extracted as secondary outcome measures. Furthermore, walking speed and surgical approach will be
reported. These secondary outcomes will be used to investigate further differences that are not reflected in
lower limb biomechanics and will be used for the meta-regression analysis, if required. 
 
Data extraction (selection and coding)
 The review process will be performed in two-stages. Firstly, all titles and abstracts retrieved by electronic
searching will be imported into a cloud based password protected folder with author, year, title and journal of
publication input into Microsoft Excel. Using the descriptive information in the Excel workbook duplicates will
be removed. Two reviewers will screen titles and abstracts of all identified citations to identify potential
studies and all potentially eligible studies will be categorised as either ’retrieve’ (eligible, potentially eligible,
unclear) or ’do not retrieve’. The full text of study reports and publications coded as ’retrieve’ will be
obtained. Then, the full text will be screened to identify studies for inclusion. If a study is excluded, the
reason(s) for exclusion of the ineligible studies will be recorded in a ’Characteristics of excluded studies’
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table. If the two authors disagree over the eligibility of a particular article, a third reviewer will be consulted.
The selection process will be documented using Covidence and the details of the search will be presented in
a PRISMA checklist. We will use a modified EPOC data collection form to capture study characteristics and
outcome data. Two review authors will independently extract the following study characteristics from included
studies, if available: 
1. Methods: study design, follow-up period, biomechanical model 
2. Participants: number, mean age, age range, gender, diagnostic criteria, inclusion and exclusion criteria,
other relevant characteristics (e.g. surgical approach, type of THA [(un)cemented component]) 
3. Outcomes: main and other outcomes specified and collected, time points reported; 
4. Notes: funding for trial, notable conflicts of interest of trial authors, and ethical approval. 
5. Outcome data that is not adequately reported in the studies a usable way will be highlighted. 
The extracted data will be presented in a table of characteristics of included studies. For studies where only
a subset of the participants is eligible for inclusion, the data for the subgroup will be reported separately 
 
Risk of bias (quality) assessment
Owing to the potential risk of bias arising from both different study designs as well as outcome (kinematics
and kinetics) assessments, the methodological risk of bias (within studies) will be assessed using; a) a
critical appraisal tool (CAT) or b) the Downs and Black (1998) checklist for observational studies, as
appropriate. There may be an opportunity and potential to merge several established checklists specific to
THA analysis studies but a decision to do this will be guided and justified by revelations of the initial scoping
exercise in terms of each tool’s relevance vis a vis our research questions, ease of use and sufficient
numbers of particular types of study designs. The scoring of individual studies will be independently carried
out by two reviewers, with any disagreements resolved with the opinion (consensus) of a third reviewer if
required. 
The above within study risk of bias assessment can be viewed as a prerequisite to assessing bias across
studies to check quality of evidence or effect estimate accuracy. If it is seen that studies (or a considerate
number of adequately powered studies) have been appropriately conducted and are relatively resistant to
bias, a well thought out meta-analysis will be attempted along with a suitable global standard for rating
evidence quality. The inclusion of bias scores in a meta-regression will investigate whether any identified
study bias contributed significantly to heterogeneity. This will be supported by contour-enhanced funnel plots
and complemented by performing either the Begg’s or Egger’s regression test as appropriate depending on
quality and size of studies to assess funnel plot asymmetry. Aside from somewhat enabling the classification
of the strength of evidence as strong, moderate or limited, these findings will advise the suitability of
reporting of adjusted effect estimates with respect to either specific study designs, relative benefits or risk
factors of THA and type as well as timings of THA assessment outcomes. Any quantitative results not
included in the meta-analysis due to a different manner of reporting will be checked for their consistency with
meta-analysis results by the reviewers. A well-established standardised guide for carrying out a systematic
review such as PRISMA or STROBE, as appropriate, will be used to assess the quality of this review
process. 
 
Strategy for data synthesis
It is anticipated that there will be numerous THA outcome variables reported that are also measured across
variable time points that will in turn be summarised differently. Therefore, we will employ the ‘best’
structured synthesis of data to meet our research objectives. In as much as this is a challenge potentially
also compounded by different patient characteristics, the speed and type of functionality assessed and
surgical (intervention) approaches, it is a finding in itself which we will endeavour to adequately report.
Specifically data synthesis may be frustrated by the fact that different a) studies even if of similar design will
report summary follow up time or pre and post-operative comparisons at different time points b) studies may
report different summary follow up statistical measures e.g. means while others use medians and inter
quartile ranges (IQR) or two studies report medians that are computed differently. 
A decision on the most appropriate method to standardize, pool or amalgamate differently reported variable
estimates will be driven by any detail that can be gleaned to the type of their distributions, specific study
sample sizes and time between follow-up time or pre and post-operative periods. In instances where
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variation (or standard deviation) of biomechanical THA parameters is not available we will pursue the
possibility of either a) using a p value’s equivalent T-statistic of the mean difference between pre and post-
operative estimates to compute the standard error of the mean difference b) using a suitable standard error
of a mean difference from appropriate comparable literature to the study in question advised by a ‘sensitivity
analysis’ c) as appropriate we will attempt reaching out to authors to get additional unreported information in
line with our planned analysis. In the likely event that this is not forthcoming, the reported estimate will be
appropriately transformed to meet our analysis obligations. 
A typical spread sheet such as Excel will be used to extract data and facilitate efficient sharing of
responsibilities of several reviewers which can be easily exported to suitable analysis software. A meta-
analysis (where possible) will be applied to compute 95% confidence intervals (CIs) for pooled standardised
mean differences (SMD) effects using the inverse variance method in RevMan software (v5.2). These will be
reported depending on the extent of heterogeneity that will likely be driven by the variability of study designs
and consistency of outcome measures used in the studies included. By conservatively setting the statistical
significance at p&lt;0.10, the observed heterogeneity will be assessed where possible using the ?² test,
Cochrane’s Q statistic and I² statistic. The interpretation of heterogeneity will follow Cochrane guidelines,
where 25, 50 and 75% represent low, moderate and high heterogeneity, respectively. 
 
Analysis of subgroups or subsets
Sub-group analysis and meta-regression, where appropriate, will be conducted to explore any potential effect
of surgical approach, walking speed, pain, function, quality of life, participation and hip function upon trunk
and lower limb kinematic/kinetic parameters during walking gait.
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